Organovo Logo (2 Color Med-Res-082117).png
Organovo Announces Adjournment of Annual Meeting of Shareholders Due to Lack of Quorum
September 17, 2021 16:10 ET | Organovo, Inc.
SOLANA BEACH, Calif., Sept. 17, 2021 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO), today announced that the Company’s annual meeting of shareholders, on September 14, 2021, at 9:00...
Organovo Logo (2 Color Med-Res-082117).png
Organovo Announces Participation at the H.C. Wainwright Global Life Sciences Conference March 9-10 2021 (VIRTUAL CONFERENCE)
March 02, 2021 08:05 ET | Organovo, Inc.
SOLANA BEACH, Calif., March 02, 2021 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO), today announced it will be featured as a presenting company at the H.C. Wainwright Global Life...
Organovo Logo (2 Color Med-Res-082117).png
Organovo Regains Compliance with Nasdaq Minimum Bid Price Requirement
September 03, 2020 16:05 ET | Organovo, Inc.
SAN DIEGO, Sept. 03, 2020 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (“Organovo” or the “Company”) (Nasdaq: ONVO) announced today that it has regained compliance with the minimum bid price...
Organovo Logo (2 Color Med-Res-082117).png
Organovo Announces One-for-Twenty Reverse Stock Split
August 17, 2020 08:05 ET | Organovo, Inc.
SAN DIEGO, Aug. 17, 2020 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (the “Company”) (Nasdaq: ONVO) today announced that it filed a certificate of second amendment to its certificate of...
Organovo Logo (2 Color Med-Res-082117).png
Organovo Acknowledges Receipt of Proposal
October 02, 2019 19:31 ET | Organovo, Inc.
SAN DIEGO, Oct. 02, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ: ONVO) (“Organovo”) today confirmed that it has received a proposal from Viscient Biosciences (“Viscient”), an...
Organovo Logo (2 Color Med-Res-082117).png
Organovo to Explore Strategic Alternatives and Implement Restructuring Plan
August 07, 2019 09:00 ET | Organovo, Inc.
SAN DIEGO, Aug. 07, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) today announced that it has engaged Roth Capital Partners (“Roth”) as its financial advisor to assist...
Organovo Logo (2 Color Med-Res-082117).png
Organovo Announces Release Date for Fiscal First-Quarter 2020 Financial Results
July 18, 2019 08:05 ET | Organovo, Inc.
SAN DIEGO, July 18, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) will host a conference call on Thursday, August 8, 2019 at 5:00 p.m. Eastern Time (ET) to discuss the...
Organovo Logo (2 Color Med-Res-082117).png
Organovo Presents Data on Creating Stem Cell-Based Bioprinted Kidney Organoids at the International Society for Stem Cell Research (ISSCR) 2019 Annual Meeting
July 08, 2019 08:05 ET | Organovo, Inc.
SAN DIEGO, July 08, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a biotechnology company pioneering the development of 3D bioprinted tissues aimed at treating a range...
Organovo Logo (2 Color Med-Res-082117).png
Organovo to Present at Raymond James Life Sciences and MedTech Conference
June 13, 2019 08:05 ET | Organovo, Inc.
SAN DIEGO, June 13, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a biotechnology company pioneering the development of 3D bioprinted tissues aimed at treating a range...
Organovo Logo (2 Color Med-Res-082117).png
Organovo Collaborates With MCRI and Leiden University Medical Center to Develop Stem Cell-Based Bioprinted Tissue Treatments for Kidney Disease
May 30, 2019 08:05 ET | Organovo, Inc.
SAN DIEGO, May 30, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a biotechnology company pioneering the development of 3D bioprinted tissues aimed at treating a range...